The median percentage of CD123-expressing cells was 52.94% (range: 0.1–99.9%) and 48.69% (range: 0.00–99.8%) in the CCLG-ALL-2008 and the CCCG-ALL-2015 cohorts, respectively (Figure S1). This evidence concerns the gene IL3RA and acute lymphoblastic leukemia.